Avinger, Inc. (AVGR)
NASDAQ: AVGR · IEX Real-Time Price · USD
3.770
+0.110 (3.01%)
At close: Apr 29, 2024, 4:00 PM
3.780
+0.010 (0.27%)
After-hours: Apr 29, 2024, 5:45 PM EDT

Avinger Revenue

In the year 2023, Avinger had annual revenue of $7.65M, a decrease of -7.51%. Revenue in the quarter ending December 31, 2023 was $1.91M, a -4.75% decrease year-over-year.

Revenue (ttm)
$7.65M
Revenue Growth
-7.51%
P/S Ratio
0.84
Revenue / Employee
$112,529
Employees
68
Market Cap
6.42M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20237.65M-621.00K-7.51%
Dec 31, 20228.27M-1.86M-18.33%
Dec 31, 202110.13M1.37M15.63%
Dec 31, 20208.76M-370.00K-4.05%
Dec 31, 20199.13M1.22M15.36%
Dec 31, 20187.92M-2.02M-20.32%
Dec 31, 20179.93M-9.28M-48.30%
Dec 31, 201619.21M8.50M79.35%
Dec 31, 201510.71M-500.00K-4.46%
Dec 31, 201411.21M-1.75M-13.51%
Dec 31, 201312.96M4.40M51.45%
Dec 31, 20128.56M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
OpGen 3.07M
Xenetic Biosciences 2.54M
Mangoceuticals 731.49K
Azitra 686.00K
Assure Holdings 255.00K
Titan Pharmaceuticals 184.00K
Heart Test Laboratories 18.60K
Revenue Rankings